Lansoprazole detailed information

Lansoprazole (lan-SOE-pra-zole, INN) is a proton pump inhibitor which prevents the stomach from producing acid. It is manufactured by a number of companies worldwide under several trade names. It was first approved by the FDA in 1995.

Pharmacology
Lansoprazole is a proton pump inhibitor (PPI) in the same pharmacologic class as omeprazole. Lansoprazole has been marketed for many years and is one of several PPI's available.

Lansoprazole's plasma elimination half-life is not proportional to the duration of the drug's effects (i.e. gastric acid suppression). The mean plasma elimination half-life is 1.5 hours, and the effects of the drug last for over 24 hours after it has been used for 1 day or more.

Indications
Lansoprazole is indicated for:
 * Treatment of ulcers of the stomach and duodenum, and NSAID-induced ulcers
 * Treatment of gastroesophageal reflux disease (GERD) (also known as acid reflux disease)
 * Treatment of Zollinger-Ellison Syndrome
 * Adjunctive treatment of Helicobacter pylori infection, alongside antibiotics

Drug Interactions

 * PPI’s reduce absorption of antifungals (itraconazole and ketoconazole) and possibly increase Digoxin in plasma
 * Increases plasma concentrations of Cilostazol (risk of toxicity)
 * Absorption of lansoprazole possibly reduced by:
 * sucralfate
 * ampicillin
 * bisacodyl
 * delavirdine
 * fluvoxamine
 * iron salts
 * theophylline
 * voriconazole
 * aminophylline and theophylline
 * astemizole

Side effects

 * Infrequent: dry mouth, insomnia, drowsiness, blurred vision, rash, pruritus
 * Rarely and very rarely: taste disturbance, liver dysfunction, peripheral oedema, hypersensitivity reactions (including bronchospasm, urinary, angioedema, anaphylaxis), photosensitivity, fever, sweating, depression, interstitial nephritis, blood disorders (including leukopenia, leukocytosis, pancytopenia, thrombocytopenia), arthralgia, myalgia, skin reactions (including Stevens-Johnson syndrome, toxic epidermal necrolysis, bullous eruption)
 * Severe: Gastro-intestinal disturbances (such as nausea 1.3%, abdominal pain 2.1%, diarrhea 3.8%

Brand names
The drug is sold under several brand names, including:
 * Aprazol (Turkey)
 * Duogast (Syria)
 * Lanpro (India)
 * Lansox (Italy)
 * Lanton (Israel)
 * Lanzor (France)
 * Laprazol (Greece)
 * Limpidex (Italy)
 * Ogast and OgastORO (France)
 * Prevacid (U.S. and Canada) Prevacid is a product of TAP Pharmaceutical Products.
 * Prosogan and Prosogan FD (Indonesia)
 * Refluxon (Hungary)
 * SOLOX (New Zealand)
 * Takepron (Japan)
 * Zoton (Italy, Ireland, Australia, UK)

Lansoprazole is also available as a generic drug in the UK, Belgium, France, Colombia, Italy and Mexico.